Shopping Cart
- Remove All
Your shopping cart is currently empty
PF-06463922 acetate is a potent, selective brain-penetrable inhibitor of both anaplastic lymphoma kinase (ALK) and c-ros Oncogene 1 (ROS1) with strong activity against all known ALK and ROS1 mutants identified in patients with crizotinib-resistant disease. PF-06463922 is in clinical trials for the treatment of non–small cell lung cancer (NSCLC).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,420 | 10-14 weeks | |
| 50 mg | $3,180 | 10-14 weeks | |
| 100 mg | $4,300 | 10-14 weeks |
| Description | PF-06463922 acetate is a potent, selective brain-penetrable inhibitor of both anaplastic lymphoma kinase (ALK) and c-ros Oncogene 1 (ROS1) with strong activity against all known ALK and ROS1 mutants identified in patients with crizotinib-resistant disease. PF-06463922 is in clinical trials for the treatment of non–small cell lung cancer (NSCLC). |
| Molecular Weight | 466.46 |
| Formula | C23H23FN6O4 |
| Cas No. | 1924207-18-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.